Cycle for Survival is the national movement to beat rare cancers. It was founded in 2007 when David Linn and his late wife Jen gathered a few friends along with his colleagues at Oak Point Partners. Cycle for Survival has raised over $250M to beat rare cancers and funded over 100 clinical trials, research studies, and major research initiatives.
The high-energy indoor team cycling events provide a tangible way for you to fight back—100% of all money raised directly funds lifesaving rare cancer research.
Incredibly, it is now a national movement to beat rare cancers, and it’s the fastest-growing athletic fundraiser in the country! Cycle for Survival is owned and operated by Memorial Sloan Kettering Cancer Center, and Equinox is the founding partner.
As you can see in the photos below, a huge number of restructuring and private equity firms have formed teams to ride in Cycle for Survival. These teams include: Akin Gump, AlixPartners, Alston & Bird, Apollo, Arent Fox, Ares Management, Ashby & Geddes, ASK, Bain Capital, BastAmron, BDO, Berger Singerman, Blackhill Partners, Blackstone, BMC, CBIZ, CohnReznick, Cooch and Taylor, Cozen O’Connor, Crowe Horwath, Deloitte CRG, DLA Piper, Epiq, Ernst and Young, Foley and Lardner, Fox Rothschild, Friedman LLP, FTI Consulting, Gavin / Solmonese, GlassRatner, Goldin Associates, Gordon Brothers, Hahn & Hessen, Houlihan, Jackson Walker, Jenner & Block, Jones Day, Kaye Scholer, Kramer Levin, Levene Neale Bender Yoo & Brill, Lowenstein Sandler, Marathon Asset Management, McElroy, Deutsch, McKool Smith, Melville Capital, Mesirow, MoFo, Noble Risk, Odyssey, Pachulski, Parker Ibrahim & Berg, Pritzker Group, Riker Danzig, Sentinel, Shaw Fishman, Sidley Austin, Tiger Group, Togut Segal & Segal, Vedder Price, Venable, Weil Gotshal, Whiteford Taylor, and Womble Carlyle.
To read more about how Cycle for Survival got started, please see this article